Hansen A J, Lee Y H, Sterneck E, Gonzalez F J, Mackenzie P I
Department of Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, Bedford Park, South Australia, 5042, Australia.
Mol Pharmacol. 1998 Jun;53(6):1027-33.
The rat UDP glucuronosyltransferase, UGT2B1, is expressed in the liver where it glucuronidates steroids, environmental toxins, and carcinogens. A region between -88 and -111 base pairs upstream from the UGT2B1 gene transcription start site contains a CCAAT enhancer binding protein (C/EBP)-like element and was previously shown by Dnase I footprint analysis to bind to proteins in both rat liver and human hepatoma (HepG2) cell nuclear extracts. In this study, the importance of this region in the regulation of the UGT2B1 gene was assessed by functional and DNA binding assays. Varying lengths of the UGT2B1 gene promoter, with and without the C/EBP-like element, were fused to the chloramphenicol acetyltransferase reporter gene and transfected into HepG2 cells. Transcriptional activity of the UGT2B1 promoter construct containing the C/EBP-like element was strongly elevated in the presence of a cotransfected C/EBPalpha expression vector. In contrast, no change was observed when an expression vector encoding C/EBPbeta was cotransfected with the UGT2B1 promoter constructs. Introduction of point mutations into the C/EBP-like element prevented any C/EBPalpha-mediated increase in chloramphenicol acetyltransferase activity. Gel shift analyses demonstrated that the C/EBP-like element binds a complex of nuclear proteins present in both HepG2 cells and rat liver. The presence of C/EBPalpha in this complex was confirmed by supershift analysis with antiserum to this factor. These data strongly suggest that the liver-enriched factor C/EBPalpha binds to, and activates, the UGT2B1 gene promoter. The importance of C/EBPalpha in the regulation of the homologous mouse UGT2B1 gene was also assessed in vivo. Transcripts homologous to UGT2B1 were detected in the livers of mice containing intact c/ebpalpha and c/ebpbeta genes and in mice containing a homozygous null mutation in the c/ebpbeta gene. In contrast, these transcripts were not detected in mice with a disrupted hepatic c/ebpalpha gene. These data extend the findings with the rat UGT2B1 gene promoter and establish that C/EBPalpha, but not C/EBPbeta, is an essential transcriptional regulator of the homologous UGT2B1 gene in the mouse.
大鼠尿苷二磷酸葡萄糖醛酸基转移酶UGT2B1在肝脏中表达,可使类固醇、环境毒素和致癌物发生葡萄糖醛酸化。UGT2B1基因转录起始位点上游-88至-111碱基对之间的区域含有一个CCAAT增强子结合蛋白(C/EBP)样元件,先前通过Dnase I足迹分析表明,该元件可与大鼠肝脏和人肝癌(HepG2)细胞核提取物中的蛋白质结合。在本研究中,通过功能和DNA结合试验评估了该区域在UGT2B1基因调控中的重要性。将含有和不含有C/EBP样元件的不同长度的UGT2B1基因启动子与氯霉素乙酰转移酶报告基因融合,并转染到HepG2细胞中。在共转染C/EBPα表达载体的情况下,含有C/EBP样元件的UGT2B1启动子构建体的转录活性显著升高。相反,当编码C/EBPβ的表达载体与UGT2B1启动子构建体共转染时,未观察到变化。将点突变引入C/EBP样元件可阻止C/EBPα介导的氯霉素乙酰转移酶活性增加。凝胶迁移分析表明,C/EBP样元件与HepG2细胞和大鼠肝脏中存在的核蛋白复合物结合。用针对该因子的抗血清进行超迁移分析证实了该复合物中存在C/EBPα。这些数据有力地表明,肝脏富集因子C/EBPα与UGT2B1基因启动子结合并激活该启动子。还在体内评估了C/EBPα在同源小鼠UGT2B1基因调控中的重要性。在含有完整c/ebpα和c/ebpβ基因的小鼠肝脏以及在c/ebpβ基因中含有纯合无效突变的小鼠肝脏中检测到与UGT2B1同源的转录本。相反,在肝脏c/ebpα基因被破坏的小鼠中未检测到这些转录本。这些数据扩展了大鼠UGT2B1基因启动子的研究结果,并确定C/EBPα而非C/EBPβ是小鼠同源UGT2B1基因的必需转录调节因子。